48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2(I) → 1(II))-α-D-glucopyranoside in streptozotocin induced diabetic rats.

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The objective of the present study was to evaluate the effect of umbelliferon-α-D-glucopyranosyl-(2I → 1II)-α-D-glucopyranoside (UFD) from Aegle marmelos Corr. on serum glucose, lipid profile and free radical scavenging activity in normal and STZ (streptozotocin) induced diabetic rats.

          Related collections

          Most cited references53

          • Record: found
          • Abstract: found
          • Article: not found

          Selenium: biochemical role as a component of glutathione peroxidase.

          When hemolyzates from erythrocytes of selenium-deficient rats were incubated in vitro in the presence of ascorbate or H(2)O(2), added glutathione failed to protect the hemoglobin from oxidative damage. This occurred because the erythrocytes were practically devoid of glutathione-peroxidase activity. Extensively purified preparations of glutathione peroxidase contained a large part of the (75)Se of erythrocytes labeled in vivo. Many of the nutritional effects of selenium can be explained by its role in glutathione peroxidase.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            A simplified method of evaluating dose-effect experiments.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Postprandial hyperglycemia and diabetes complications: is it time to treat?

              A Ceriello (2004)
              Increasing evidence suggests that the postprandial state is a contributing factor to the development of atherosclerosis. In diabetes, the postprandial phase is characterized by a rapid and large increase in blood glucose levels, and the possibility that the postprandial "hyperglycemic spikes" may be relevant to the onset of cardiovascular complications has recently received much attention. Epidemiological studies and preliminary intervention studies have shown that postprandial hyperglycemia is a direct and independent risk factor for cardiovascular disease (CVD). Most of the cardiovascular risk factors are modified in the postprandial phase in diabetic subjects and directly affected by an acute increase of glycemia. The mechanisms through which acute hyperglycemia exerts its effects may be identified in the production of free radicals. This alarmingly suggestive body of evidence for a harmful effect of postprandial hyperglycemia on diabetes complications has been sufficient to influence guidelines from key professional scientific societies. Correcting the postprandial hyperglycemia may form part of the strategy for the prevention and management of CVDs in diabetes.
                Bookmark

                Author and article information

                Journal
                Springerplus
                SpringerPlus
                Springer Science and Business Media LLC
                2193-1801
                2193-1801
                2013
                : 2
                Affiliations
                [1 ] Department of Pharmaceutical Sciences, Faculty of Health Sciences, Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh 211007 India.
                [2 ] Sidharatha Institute of Pharmacy, Dehradun, Uttrakhand 248001 India.
                [3 ] Department of Phytochemisty & Pharmacognosy, Faculty of Pharmacy, Jamia Hamdard, New Delhi 110062 India.
                Article
                693
                10.1186/2193-1801-2-639
                3862866
                24349947
                06aa50a5-3f73-488b-b51c-948176dec31c
                History

                Antidiabetic,Antihyperlipidemic,Glibenclamide,Streptozotocin,Umbelliferon-α-D-glucopyranosyl-(2I → 1II)-α-D-glucopyranoside

                Comments

                Comment on this article